Stocktoria
AVITA Medical, Inc. RCEL
Nasdaq · XNAS · stock · Surgical & Medical Instruments & Apparatus · website · IPO 2012-03-18
AVITA Medical, Inc. statistics & valuation
Market cap$122.2M
P / S1.7×
Market cap as of 2026-06-29. Multiples are price-derived and refreshed daily; everything else is from filings.
Key ratios (by fiscal year)
| Ratio | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Gross margin | 82.1% | 85.8% | 84.5% | 82.4% | 79.6% |
| Operating margin | -59.4% | -88.1% | -85.1% | -79.9% | -90.8% |
| Net margin | -67.8% | -96.3% | -70.6% | -77.5% | -90.9% |
| FCF margin | -45.0% | -90.4% | -78.6% | -56.8% | -91.7% |
| Return on assets | -86.2% | -77.6% | -31.7% | -27.1% | -21.2% |
| Return on equity | 291.8% | -1374.6% | -72.1% | -31.5% | -23.0% |
| Debt / equity | -0.00× | 9.39× | 0.81× | — | — |
| Current ratio | 0.57 | 2.83 | 7.88 | 8.18 | 16.42 |
| Revenue growth | 11.5% | 28.1% | 45.7% | 17.8% | 104.9% |
Source: SEC EDGAR filings · CIK 0001762303 · as of 2025-12-31. Facts from filings plus Stocktoria's own computed scores — not investment advice.